Valuation Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 2025-01-24			5-day change	1st Jan Change
180,200.00 ^KRW	+0.61%		+0.11%	-3.89%

Jan. 23	Celltrion Launches SteQeyma Across Five European Countries	MT
Jan. 14	Celltrion Unveils Strategic Vision for Advancing Its Innovative Drug Pipeline At the 43Rd Annual J.P. Morgan Healthcare Conference	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	24,175,552	48,989,351	27,592,583	23,000,359	27,970,378	38,224,008	38,224,008	-
Change	-	102.64%	-43.68%	-16.64%	21.61%	36.66%	0%	-
Enterprise Value (EV) ¹	24,047	49,090	27,117	23,236	29,280	39,325	39,113	38,565
Change	-	104.14%	-44.76%	-14.31%	26.01%	34.31%	-0.54%	-1.4%
P/E ratio	77.7x	94.4x	47.2x	41.6x	53.7x	89.9x	33.8x	24.4x
PBR	8.27x	14.4x	6.87x	5.34x	2.46x	2.3x	2.18x	2.01x
PEG	-	1.4x	3.8x	-9.54x	-20.3x	-2x	0x	0.6x
Capitalization / Revenue	21.4x	26.5x	14.6x	10.1x	12.9x	10.9x	8.62x	7.09x
EV / Revenue	21.3x	26.5x	14.3x	10.2x	13.5x	11.3x	8.82x	7.15x
EV / EBITDA	44.8x	55.1x	27.9x	26.6x	32.6x	40.6x	21x	15.7x
EV / EBIT	63.6x	68.9x	36x	35.9x	44.9x	67.8x	25.8x	18.4x
EV / FCF	63.3x	186x	46x	-211x	89.5x	42.4x	31.7x	26.8x
FCF Yield	1.58%	0.54%	2.17%	-0.47%	1.12%	2.36%	3.15%	3.73%
Dividend per Share ³	-	-	686.8	-	476.2	476.2	481.8	586.2
Rate of return	-	-	0.38%	-	0.25%	0.26%	0.27%	0.33%
EPS ³	2,051	3,415	3,839	3,671	3,574	2,004	5,333	7,393
Distribution rate	-	-	17.9%	-	13.3%	23.8%	9.04%	7.93%
Net sales ¹	1,128	1,849	1,891	2,284	2,176	3,491	4,432	5,390
EBITDA ¹	537.3	891.4	972.1	873.6	897.2	969.6	1,862	2,452
EBIT ¹	378.1	712.1	753.9	647.2	651.5	580.2	1,516	2,100
Net income ¹	297.6	511.3	575.1	533.2	535.6	458.1	1,201	1,625
Net Debt ¹	-128.5	100.4	-475.5	235.5	1,310	1,101	888.6	340.7
Reference price ³	159,314.61	322,308.41	181,318.68	152,857.14	191,904.76	180,200.00	180,200.00	180,200.00
Nbr of stocks (in thousands)	151,747	151,995	152,177	150,470	145,751	212,120	212,120	-
Announcement Date	2/19/20	2/22/21	2/16/22	3/3/23	2/29/24	-	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield	Capi. ($)
CELLTRION, INC.	89.37x	11.2x	40.32x	+0.27%	26.47B
LONZA GROUP AG	50.12x	6.84x	24.29x	+0.77%	46.39B
IQVIA HOLDINGS INC.	28.04x	3.24x	13.53x	-.--%	37.39B
ICON PUBLIC LIMITED COMPANY	23.27x	2.34x	11.18x	-.--%	16.73B
UNITED THERAPEUTICS CORPORATION	15.07x	5.02x	9.64x	-.--%	16.6B
MODERNA, INC.	-4.52x	2.66x	-2.39x	-.--%	16.31B
BIO-TECHNE CORPORATION	64.02x	9.9x	28.43x	+0.42%	12.22B
MEDPACE HOLDINGS, INC.	29.08x	4.99x	22.85x	-.--%	10.79B
QIAGEN N.V.	61.96x	5.27x	14.27x	-.--%	10.19B
Average	39.60x	5.72x	18.01x	+0.16%	21.45B
Weighted average by Cap.	41.60x	5.85x	19.41x	+0.25%